Clinical Trials on Idiopathic Pulmonary Fibrosis in United Kingdom
Total 5454 results
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); Brown UniversityCompleted
-
University of MichiganCoalition for Pulmonary FibrosisCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Korea, Republic of, Australia, Italy, United Kingdom, Germany, China, Finland, Denmark, Netherlands, Greece, Argentina, Austria, Chile, Czechia, Hungary, Japan, Poland, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisGermany, United Kingdom, Ireland, France, Austria, Denmark, Finland, Italy, Norway, Sweden
-
Sunshine Lake Pharma Co., Ltd.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States
-
SanofiCompletedIdiopathic Pulmonary FibrosisCzechia, Korea, Republic of, Mexico, Israel, Spain, Greece, Chile, Canada, Colombia, Turkey, Denmark, France, United States, Argentina, Australia, Germany, Italy, Portugal, United Kingdom
-
University of PittsburghWithdrawnIdiopathic Pulmonary FibrosisUnited States
-
The National Institutes of Pharmaceutical R&D Co...CompletedIdiopathic Pulmonary FibrosisUnited States
-
Excalibur Pharmaceuticals, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
InterMuneTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | Lung DiseaseUnited States
-
InterMuneTerminatedIdiopathic Pulmonary Fibrosis | Pulmonary Fibrosis | Lung DiseaseUnited States
-
Sunshine Lake Pharma Co., Ltd.CovanceCompletedIdiopathic Pulmonary FibrosisUnited States
-
Steward St. Elizabeth's Medical Center of Boston...Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
CelgeneTerminatedPathologic Processes | Fibrosis | Respiratory Tract Diseases | Lung Diseases | Idiopathic Pulmonary Fibrosis | Lung Diseases, Interstitial | Idiopathic Interstitial PneumoniasUnited States, Australia, Colombia, United Kingdom, Russian Federation, Brazil, Germany, Canada, Greece, Romania, Taiwan, Turkey, Ukraine
-
Nitto Denko CorporationCompletedIdiopathic Pulmonary FibrosisUnited States, Germany, Japan, United Kingdom
-
Gilead SciencesCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedPulmonary FibrosisArgentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czech Republic, France, Germany, Greece, Hungary, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan and more
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Australia, Belgium, China, Czech Republic, France, Germany, India, Ireland, Israel, Italy, Japan, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium
-
Modern Biosciences LtdRecruitingIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Israel, France, Germany, Greece, Hungary, Italy, Spain
-
Michael DonahoeCompleted
-
Galapagos NVTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Japan, Belgium, Taiwan, Denmark, Germany, United Kingdom, Greece, Australia, Czechia, Brazil, Chile, Peru, Turkey
-
BiogenTerminatedIdiopathic Pulmonary FibrosisUnited States, Italy, Belgium, Czechia, Russian Federation, Korea, Republic of, Australia, France, Israel, Spain, Poland, Netherlands, Denmark, Greece, Argentina, Chile, United Kingdom
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Novartis PharmaceuticalsCompleted
-
InterMuneCompletedPulmonary Fibrosis | Lung DiseaseUnited States
-
Trevi TherapeuticsRecruitingIdiopathic Pulmonary FibrosisUnited Kingdom, Australia, Netherlands, Spain, Italy, Poland, Turkey, Canada, Chile, Germany
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimApproved for marketingIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium, Germany, Peru, Mexico, Poland, France, Italy, United Kingdom, Australia, Canada, Spain, Japan
-
Hal ChapmanMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsRecruitingIdiopathic Pulmonary FibrosisUnited States
-
University of Alabama at BirminghamRecruitingIdiopathic Pulmonary FibrosisUnited States
-
Temple UniversityBoehringer IngelheimActive, not recruiting
-
Stanford UniversityCelgene CorporationWithdrawnPulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Belgium, Australia, United Kingdom, Canada, China, Germany, Japan, Turkey, France, Ireland, Italy, Israel, Netherlands, Portugal, Greece, India, Czechia, Chile, Finland, Mexico, Russian Federation
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedIdiopathic Pulmonary FibrosisUnited States
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Joseph C. WuNot yet recruitingIdiopathic Pulmonary FibrosisUnited States
-
University of Alabama at BirminghamCompletedIdiopathic Pulmonary FibrosisUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedIdiopathic Pulmonary FibrosisUnited States
-
Vanderbilt University Medical CenterTerminatedIdiopathic Pulmonary FibrosisUnited States
-
University of PittsburghActive, not recruitingPulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
Kadmon Corporation, LLCCompletedIdiopathic Pulmonary FibrosisUnited States
-
University of PittsburghRecruiting
-
AstraZenecaCompletedIdiopathic Pulmonary FibrosisUnited States
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
Pliant Therapeutics, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Temple UniversityBoehringer IngelheimTerminatedIdiopathic Pulmonary Fibrosis | Lung Transplant; ComplicationsUnited States